Susceptibility of cell substrates to PrP^Sc infection and safety control measures related to biological and biotherapeutical products

References

• Agostinho P, Oliveira CR. Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides. Eur J Neurosci 2003; 17:1189 - 1196
   Google Scholar
• Agrimi U, Ru G, Cardone F, Pocchiari M, Caramelli M. Epidemic of transmissible spongiform encephalopathy in sheep and goats in Italy. Lancet 1999; 353:560 - 561
   PubMed Web of Science ®Google Scholar
• Archer F, Bachelin C, Andreoletti O, Besnard N, Perrot G, Langevin C, Le DA, Vilette D, Baron-Van EA, Vilotte JL, Laude H. Cultured peripheral neuroglial cells are highly permissive to sheep prion infection. J Virol 2004; 78:482 - 490
   PubMed Web of Science ®Google Scholar
• Baeten LA, Powers BE, Jewell JE, Spraker TR, Miller MW. A natural case of chronic wasting disease in a free-ranging moose (Alces alces shirasi). J Wildl Dis 2007; 43:309 - 314
   PubMed Web of Science ®Google Scholar
• Baron GS, Magalhaes AC, Prado MA, Caughey B. Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res. J Virol 2006; 80:2106 - 2117
   PubMed Web of Science ®Google Scholar
• Bellon A, Seyfert-Brandt W, Lang W, Baron H, Groner A, Vey M. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. J Gen Virol 2003; 84:1921 - 1925
   PubMed Web of Science ®Google Scholar
• Beranger F, Mange A, Solassol J, Lehmann S. Cell culture models of transmissible spongiform encephalopathies. Biochem Biophys Res Commun 2001; 289:311 - 316
   PubMed Web of Science ®Google Scholar
• Birkett CR, Hennion RM, Bembridge DA, Clarke MC, Chree A, Bruce ME, Bostock CJ. Scrapie strains maintain biological phenotypes on propagation in a cell line in culture. EMBO J 2001; 20:3351 - 3358
   PubMed Web of Science ®Google Scholar
• Borchelt DR, Scott M, Taraboulos A, Stahl N, Prusiner SB. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 1990; 110:743 - 752
   PubMed Web of Science ®Google Scholar
• Bosque PJ, Prusiner SB. Cultured cell sublines highly susceptible to prion infection. J Virol 2000; 74:4377 - 4386
   PubMed Web of Science ®Google Scholar
• Brown DR, Schmidt B, Groschup MH, Kretzschmar HA. Prion protein expression in muscle cells and toxicity of a prion protein fragment. Eur J Cell Biol 1998; 75:29 - 37
   PubMed Web of Science ®Google Scholar
• Brown P, Brandel JP, Preece M, Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006; 67:389 - 393
   PubMed Web of Science ®Google Scholar
• Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339 - 1347
   PubMed Web of Science ®Google Scholar
• Butler DA, Scott MR, Bockman JM, Borchelt DR, Taraboulos A, Hsiao KK, Kingsbury DT, Prusiner SB. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol 1988; 62:1558 - 1564
   PubMed Web of Science ®Google Scholar
• Caramelli M, Ru G, Casalone C, Bozzetta E, Acutis PL, Calella A, Forloni G. Evidence for the transmission of scrapie to sheep and goats from a vaccine against Mycoplasma agalactiae. Vet Rec 2001; 148:531 - 536
   PubMed Web of Science ®Google Scholar
• Clarke MC, Haig DA. Evidence for the multiplication of scrapie agent in cell culture. Nature 1970; 225:100 - 101
   PubMed Web of Science ®Google Scholar
• Clarke MC, Millson GC. Infection of a cell line of mouse L fibroblasts with scrapie agent. Nature 1976; 261:144 - 145
   PubMed Web of Science ®Google Scholar
• Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 1999; 354:317 - 323
   PubMed Web of Science ®Google Scholar
• Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930 - 936
   PubMed Web of Science ®Google Scholar
• Cronier S, Laude H, Peyrin JM. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Proc Natl Acad Sci USA 2004; 101:12271 - 12276
   PubMed Web of Science ®Google Scholar
• Daude N, Marella M, Chabry J. Specific inhibition of pathological prion protein accumulation by small interfering RNAs. J Cell Sci 2003; 116:2775 - 2779
   PubMed Web of Science ®Google Scholar
• Dlakic WM, Grigg E, Bessen RA. Prion infection of muscle cells in vitro. J Virol 2007; 81:4615 - 4624
   PubMed Web of Science ®Google Scholar
• Flan B, Arrabal S. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal. Transfus Clin Biol 2007; 14:51 - 62
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration Accessed 2008 (FDA, http://www.fda.gov/ora/inspect_ref/iom/ChapterText/5_7.html)
   Google Scholar
• Foster PR, Griffin BD, Bienek C, McIntosh RV, MacGregor IR, Somerville RA, Steele PJ, Reichl HE. Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII. Vox Sang 2004; 86:92 - 99
   PubMed Web of Science ®Google Scholar
• Foster PR, Welch AG, McLean C, Griffin BD, Hardy JC, Bartley A, MacDonald S, Bailey AC. Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products. Vox Sang 2000; 78:86 - 95
   PubMed Web of Science ®Google Scholar
• Franscini N, El GA, Matthey U, Franitza S, Sy MS, Burkle A, Groschup M, Braun U, Zahn R. Prion protein in milk. PLoS ONE 2006; 1:71
   PubMed Web of Science ®Google Scholar
• Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, Rieger R, Krasemann S, Deslys JP, Dormont D, Lasmezas CI, Weiss S. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 2001; 20:5863 - 5875
   PubMed Web of Science ®Google Scholar
• Giri RK, Young R, Pitstick R, DeArmond SJ, Prusiner SB, Carlson GA. Prion infection of mouse neurospheres. Proc Natl Acad Sci USA 2006; 103:3875 - 3880
   PubMed Web of Science ®Google Scholar
• Hayflick L. A brief history of cell substrates used for the preparation of human biologicals. Dev Biol (Basel) 2001; 106:5 - 23
   PubMedGoogle Scholar
• Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR. A transmembrane form of the prion protein in neurodegenerative disease. Science 1998; 279:827 - 834
   PubMed Web of Science ®Google Scholar
• Hetz C, Russelakis-Carneiro M, Maundrell K, Castilla J, Soto C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J 2003; 22:5435 - 5445
   PubMed Web of Science ®Google Scholar
• Hewitt PE, Llewelyn CA, Mackenzie J, Will RG. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 2006; 91:221 - 230
   PubMed Web of Science ®Google Scholar
• Hijazi N, Kariv-Inbal Z, Gasset M, Gabizon R. PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. J Biol Chem 2005; 280:17057 - 17061
   PubMed Web of Science ®Google Scholar
• Hope J, Reekie LJ, Hunter N, Multhaup G, Beyreuther K, White H, Scott AC, Stack MJ, Dawson M, Wells GA. Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature 1988; 336:390 - 392
   PubMed Web of Science ®Google Scholar
• Horonchik L, Tzaban S, Ben-Zaken O, Yedidia Y, Rouvinski A, Papy-Garcia D, Barritault D, Vlodavsky I, Taraboulos A. Heparan sulfate is a cellular receptor for purified infectious prions. J Biol Chem 2005; 280:17062 - 17067
   PubMed Web of Science ®Google Scholar
• Huang H, Rendulich J, Stevenson D, O'Rourke K, Balachandran A. Evaluation of Western blotting methods using samples with or without sodium phosphotungstic acid precipitation for diagnosis of scrapie and chronic wasting disease. Can J Vet Res 2005; 69:193 - 199
   PubMed Web of Science ®Google Scholar
• Hunter N. Scrapie: uncertainties, biology and molecular approaches. Biochim Biophys Acta 2007; 1772:619 - 628
   Google Scholar
• Ironside JW, Head MW. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products. Haemophilia 2004; 10:64 - 69
   PubMed Web of Science ®Google Scholar
• Jones M, Peden AH, Prowse CV, Groner A, Manson JC, Turner ML, Ironside JW, MacGregor IR, Head MW. In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol 2007; 213:21 - 26
   PubMed Web of Science ®Google Scholar
• Klein MA, Frigg R, Raeber AJ, Flechsig E, Hegyi I, Zinkernagel RM, Weissmann C, Aguzzi A. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat Med 1998; 4:1429 - 1433
   PubMedGoogle Scholar
• Klohn PC, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci USA 2003; 100:11666 - 11671
   PubMed Web of Science ®Google Scholar
• Knight R. Creutzfeldt-Jakob disease: a protein disease. Proteomics 2001; 1:763 - 766
   PubMed Web of Science ®Google Scholar
• Knight R. Variant CJD: the present position and future possibilities. Int J Pediatr Otorhinolaryngol 2003; 67:81 - 84
   PubMed Web of Science ®Google Scholar
• Knight R. Creutzfeldt-Jakob disease: a rare cause of dementia in elderly persons. Clin Infect Dis 2006; 43:340 - 346
   PubMed Web of Science ®Google Scholar
• Kreil TR, Wieser A, Berting A, Spruth M, Medek C, Polsler G, Gaida T, Hammerle T, Teschner W, Schwarz HP, Barrett PN. Removal of small nonenveloped viruses by antibody- enhanced nanofiltration during the manufacture of plasma derivatives. Transfusion 2006; 46:1143 - 1151
   PubMed Web of Science ®Google Scholar
• Ladogana A, Liu Q, Xi YG, Pocchiari M. Proteinase-resistant protein in human neuroblastoma cells infected with brain material from Creutzfeldt-Jakob patient. Lancet 1995; 345:594 - 595
   PubMed Web of Science ®Google Scholar
• LeBrun M, Huang H, He R, Booth S, Balachandran A, Li X. Comparison of Trichloroacetic Acid with Other Protein-Precipitating Agents in Enriching Abnormal Prion Protein for Western Blot Analysis. Can J Microbiol 2008; 54:467 - 471
   PubMed Web of Science ®Google Scholar
• Lee DC, Stenland CJ, Miller JL, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, Rubenstein R, Fournel M, Petteway SR Jr. A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion 2001; 41:449 - 455
   PubMed Web of Science ®Google Scholar
• Leucht C, Simoneau S, Rey C, Vana K, Rieger R, Lasmezas CI, Weiss S. The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep 2003; 4:290 - 295
   PubMed Web of Science ®Google Scholar
• Lewis AM, Yu M, DeArmond SJ, Dillon WP, Miller BL, Geschwind MD. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging. Arch Neurol 2006; 63:288 - 290
   PubMed Web of Science ®Google Scholar
• Ma J, Lindquist S. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 2002; 298:1785 - 1788
   PubMed Web of Science ®Google Scholar
• Markovits P, Dautherville C, Dormont D, Dianoux L, Latarjet R. In vitro propagation of the scrapie agent I. Transformation of mouse glia and neuroblastoma cells after infection with the mouse-adapted scrapie strain c-506. Acta Neuropathol 1983; 60:75 - 80
   PubMed Web of Science ®Google Scholar
• Martinez del HG, Lopez-Bravo M, Metharom P, Ardavin C, Aucouturier P. Prion protein expression by mouse dendritic cells is restricted to the nonplasmacytoid subsets and correlates with the maturation state. J Immunol 2006; 177:6137 - 6142
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Fu YX, Molina H, Huang G, Kim J, Thomas DA, Nahm MH, Chaplin DD. Distinct roles of lymphotoxin alpha and the type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-bone marrow-derived cells. J Exp Med 1997; 186:1997 - 2004
   PubMed Web of Science ®Google Scholar
• Melo JB, Agostinho P, Oliveira CR. Prion protein aggregation and neurotoxicity in cortical neurons. Ann N Y Acad Sci 2007; 1096:220 - 229
   PubMed Web of Science ®Google Scholar
• Milhavet O, Casanova D, Chevallier N, McKay RD, Lehmann S. Neural stem cell model for prion propagation. Stem Cells 2006; 24:2284 - 2291
   PubMed Web of Science ®Google Scholar
• Montrasio F, Frigg R, Glatzel M, Klein MA, Mackay F, Aguzzi A, Weissmann C. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 2000; 288:1257 - 1259
   PubMed Web of Science ®Google Scholar
• Moore RA, Vorberg I, Priola SA. Species barriers in prion diseases—brief review. Arch Virol 2005; 187 - 202
   Web of Science ®Google Scholar
• Morel E, Andrieu T, Casagrande F, Gauczynski S, Weiss S, Grassi J, Rousset M, Dormont D, Chambaz J. Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor. Am J Pathol 2005; 167:1033 - 1042
   PubMed Web of Science ®Google Scholar
• Nelson J, McFerran NV, Pivato G, Chambers E, Doherty C, Steele D, Timson DJ. The 67 kDa laminin receptor: structure, function and role in disease. Biosci Rep 2008; 28:33 - 48
   PubMed Web of Science ®Google Scholar
• Nishida N, Harris DA, Vilette D, Laude H, Frobert Y, Grassi J, Casanova D, Milhavet O, Lehmann S. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol 2000; 74:320 - 325
   PubMed Web of Science ®Google Scholar
• Paquet S, Daude N, Courageot MP, Chapuis J, Laude H, Vilette D. PrPC does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells. J Virol 2007; 81:10786 - 10791
   PubMed Web of Science ®Google Scholar
• Pocchiari M, Macchi G, Peano S, Conz A. Can potential hazard of Creutzfeldt-Jakob disease infectivity be reduced in the production of human growth hormone? Inactivation experiments with the 263 K strain of scrapie. Rapid communication Arch Virol 1988; 98:131 - 135
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337 - 348
   PubMed Web of Science ®Google Scholar
• Race RE, Fadness LH, Chesebro B. Characterization of scrapie infection in mouse neuroblastoma cells. J Gen Virol 1987; 68:1391 - 1399
   PubMedGoogle Scholar
• Raeber AJ, Oesch B. Diagnostics for TSE agents. Dev Biol (Basel) 2006; 123:313 - 323
   PubMedGoogle Scholar
• Raymond GJ, Olsen EA, Lee KS, Raymond LD, Bryant PK III, Baron GS, Caughey WS, Kocisko DA, McHolland LE, Favara C, Langeveld JP, van Zijderveld FG, Mayer RT, Miller MW, Williams ES, Caughey B. Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease. J Virol 2006; 80:596 - 604
   PubMed Web of Science ®Google Scholar
• Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975; 6:331 - 433
   PubMed Web of Science ®Google Scholar
• Rubenstein R, Carp RI, Callahan SM. In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J Gen Virol 1984; 65:2191 - 2198
   PubMed Web of Science ®Google Scholar
• Rubenstein R, Deng H, Scalici CL, Papini MC. Alterations in neurotransmitter-related enzyme activity in scrapie-infected PC12 cells. J Gen Virol 1991; 72:1279 - 1285
   PubMed Web of Science ®Google Scholar
• Rybner-Barnier C, Jacquemot C, Cuche C, Dore G, Majlessi L, Gabellec MM, Moris A, Schwartz O, Di SJ, Cumano A, Leclerc C, Lazarini F. Processing of the bovine spongiform encephalopathy-specific prion protein by dendritic cells. J Virol 2006; 80:4656 - 4663
   PubMed Web of Science ®Google Scholar
• Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810 - 813
   PubMed Web of Science ®Google Scholar
• Sakudo A, Nakamura I, Ikuta K, Onodera T. Recent developments in prion disease research: diagnostic tools and in vitro cell culture models. J Vet Med Sci 2007; 69:329 - 337
   PubMed Web of Science ®Google Scholar
• Santuccione A, Sytnyk V, Leshchyns'ka I, Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 2005; 169:341 - 354
   PubMed Web of Science ®Google Scholar
• Schatzl HM, Laszlo L, Holtzman DM, Tatzelt J, DeArmond SJ, Weiner RI, Mobley WC, Prusiner SB. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol 1997; 71:8821 - 8831
   PubMed Web of Science ®Google Scholar
• Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE, Prusiner SB. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 2001; 314:1209 - 1225
   PubMed Web of Science ®Google Scholar
• Schonberger O, Horonchik L, Gabizon R, Papy-Garcia D, Barritault D, Taraboulos A. Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis. Biochem Biophys Res Commun 2003; 312:473 - 479
   PubMed Web of Science ®Google Scholar
• Shyu WC, Lin SZ, Chiang MF, Ding DC, Li KW, Chen SF, Yang HI, Li H. Overexpression of PrPC by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. J Neurosci 2005; 25:8967 - 8977
   PubMed Web of Science ®Google Scholar
• Sivaraman T, Kumar TK, Jayaraman G, Yu C. The mechanism of 2,2,2-trichloroacetic acid-induced protein precipitation. J Protein Chem 1997; 16:291 - 297
   PubMedGoogle Scholar
• Solassol J, Crozet C, Lehmann S. Prion propagation in cultured cells. Br Med Bull 2003; 66:87 - 97
   PubMed Web of Science ®Google Scholar
• Tateishi J, Kitamoto T, Mohri S, Satoh S, Sato T, Shepherd A, Macnaughton MR. Scrapie removal using Planova virus removal filters. Biologicals 2001; 29:17 - 25
   PubMed Web of Science ®Google Scholar
• Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: A review. Vet J 2000; 159:10 - 17
   PubMed Web of Science ®Google Scholar
• Taylor DR, Hooper NM. The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem J 2007; 402:17 - 23
   Google Scholar
• Thumdee P, Ponsuksili S, Murani E, Nganvongpanit K, Gehrig B, Tesfaye D, Gilles M, Hoelker M, Jennen D, Griese J, Schellander K, Wimmers K. Expression of the prion protein gene (PRNP) and cellular prion protein (PrPC) in cattle and sheep fetuses and maternal tissues during pregnancy. Gene Expr 2007; 13:283 - 297
   PubMed Web of Science ®Google Scholar
• Thyer J, Unal A, Thomas P, Eaton B, Bhashyam R, Ortenburg J, Uren E, Middleton D, Selleck P, Maher D. Prion-removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins. Vox Sang 2006; 91:292 - 300
   PubMed Web of Science ®Google Scholar
• Trejo SR, Hotta JA, Lebing W, Stenland C, Storms RE, Lee DC, Li H, Petteway S, Remington KM. Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process. Vox Sang 2003; 84:176 - 187
   PubMed Web of Science ®Google Scholar
• Trifilo MJ, Ying G, Teng C, Oldstone MB. Chronic wasting disease of deer and elk in transgenic mice: oral transmission and pathobiology. Virology 2007; 365:136 - 143
   PubMed Web of Science ®Google Scholar
• Turnbull S, Tabner BJ, Brown DR, Allsop D. Copper-dependent generation of hydrogen peroxide from the toxic prion protein fragment PrP106–126. Neurosci Lett 2003; 336:159 - 162
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Bovine Spongiform Encephalopathy (BSE): Questions and Answers on Bovine Spongiform Encephalopathy. Internet 2004; Ref Type: Electronic Citation
   Google Scholar
• Vana K, Zuber C, Nikles D, Weiss S. Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell Mol Neurobiol 2007; 27:107 - 128
   PubMed Web of Science ®Google Scholar
• Vilette D, Andreoletti O, Archer F, Madelaine MF, Vilotte JL, Lehmann S, Laude H. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci USA 2001; 98:4055 - 4059
   PubMed Web of Science ®Google Scholar
• Vorberg I, Raines A, Story B, Priola SA. Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. J Infect Dis 2004; 189:431 - 439
   Google Scholar
• Westergard L, Christensen HM, Harris DA. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 2007; 1772:629 - 644
   PubMed Web of Science ®Google Scholar
• Zabel MD, Heikenwalder M, Prinz M, Arrighi I, Schwarz P, Kranich J, von TA, Haas KM, Zeller N, Tedder TF, Weis JH, Aguzzi A. Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. J Immunol 2007; 179:6144 - 6152
   Google Scholar
• Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, de OE, Jachieri SG, Burlingame A, Huang L, Linden R, Brentani RR, Martins VR. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 2002; 21:3307 - 3316
   PubMed Web of Science ®Google Scholar
• Zanusso G, Casalone C, Acutis P, Bozzetta E, Farinazzo A, Gelati M, Fiorini M, Forloni G, Sy MS, Monaco S, Caramelli M. Molecular analysis of iatrogenic scrapie in Italy. J Gen Virol 2003; 84:1047 - 1052
   PubMed Web of Science ®Google Scholar